Advanced search
Publication Cover
Journal of Liposome Research Volume 3, 1993 - Issue 3
Submit an article Journal homepage
62
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Complexes of Amphotericin B and Cholesteryl Sulfate

Luke S. S. Guo Liposome Technology, Inc., 1050 Hamilton Court, Menlo Park, CA, 94025
&
Peter K. Working Liposome Technology, Inc., 1050 Hamilton Court, Menlo Park, CA, 94025
Pages 473-490 | Published online: 28 Sep 2008

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Masoud Ghorbani & Ramin Farhoudi. (2018) Leishmaniasis in humans: drug or vaccine therapy?. Drug Design, Development and Therapy 12, pages 25-40.
Read now
Suresh P Vyas & Swati Gupta. (2006) Optimizing efficacy of amphotericin B through nanomodification. International Journal of Nanomedicine 1:4, pages 417-432.
Read now
Theodore F. Taraschi & Joseph M. Beggs. (2000) Letters. Journal of Liposome Research 10:1, pages 96-98.
Read now
P.J. Sperry, D.J. Cua, S.A. Wetzel & J.P. Adler-Moore. (1998) Antimicrobial activity of AmBisome and non-liposomal amphotericin B following uptake of Candida glabrata by murine epidermal Langerhans cells. Medical Mycology 36:3, pages 135-141.
Read now
Yechezkel Barenholz & Rivka Cohen. (1995) Rational design of amphiphile-based drug carriers and sterically stabilized carriers. Journal of Liposome Research 5:4, pages 905-932.
Read now
Francis C. Szoka & Mary Tang. (1993) Amphotericin B Formulated in Liposomes and Lipid Based Systems: A Review. Journal of Liposome Research 3:3, pages 363-375.
Read now

Articles from other publishers (21)

Shobha Kumari, Vikash Kumar, Ritesh Kumar Tiwari, Vidyanand Ravidas, Krishna Pandey & Ashish Kumar. (2022) Amphotericin B: A drug of choice for Visceral Leishmaniasis. Acta Tropica 235, pages 106661.
Crossref
Khadijeh Rajablou, Hossein Attar, Seyed Kazem Sadjady & Amir Heydarinasab. (2022) The in-vitro study of novel phospholipid micelles loaded with amphotericin B on plasmodium falciparum protozoan. Chemistry and Physics of Lipids 245, pages 105180.
Crossref
Neena Goyal, Manveer Patel & Sanjay Batra. 2021. Drug Discovery and Drug Development. Drug Discovery and Drug Development 123 158 .
F. FogliaS. E. RogersJ. R. P. WebsterF. A. Akeroyd, K. F. Gascoyne, M. J. LawrenceD. J. Barlow. (2015) Neutron Scattering Studies of the Effects of Formulating Amphotericin B with Cholesteryl Sulfate on the Drug’s Interactions with Phospholipid and Phospholipid–Sterol Membranes. Langmuir 31:29, pages 8042-8051.
Crossref
J. A. Olson, J. A. Schwartz, D. Hahka, N. Nguyen, T. Bunch, G. M. Jensen & J. P. Adler-Moore. (2014) Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice. Medical Mycology 53:2, pages 107-118.
Crossref
Michael N. Oda, Peter L. Hargreaves, Jennifer A. Beckstead, Katherine A. Redmond, Rik van Antwerpen & Robert O. Ryan. (2006) Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B. Journal of Lipid Research 47:2, pages 260-267.
Crossref
Peter L. Hargreaves, Thanh-Son Nguyen & Robert O. Ryan. (2006) Spectroscopic studies of amphotericin B solubilized in nanoscale bilayer membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes 1758:1, pages 38-44.
Crossref
Begoña Brime, Gloria Molero, Paloma Frutos & Gloria Frutos. (2004) Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil–water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans. European Journal of Pharmaceutical Sciences 22:5, pages 451-458.
Crossref
Malika Larabi, Annette Gulik, Jean-Paul Dedieu, Philippe Legrand, Gillian Barratt & Monique Cheron. (2004) New lipid formulation of amphotericin B: spectral and microscopic analysis. Biochimica et Biophysica Acta (BBA) - Biomembranes 1664:2, pages 172-181.
Crossref
Begoña Brime, Marco A. Moreno, Gloria Frutos, Ma.Paloma Ballesteros & Paloma Frutos. (2002) Amphotericin B in Oil–Water Lecithin-Based Microemulsions: Formulation and Toxicity Evaluation. Journal of Pharmaceutical Sciences 91:4, pages 1178-1185.
Crossref
Luke S.S Guo. (2001) Amphotericin B colloidal dispersion: an improved antifungal therapy. Advanced Drug Delivery Reviews 47:2-3, pages 149-163.
Crossref
Adedayo AdedoyinChristine E. Swenson, Lois E. Bolcsak, Andrzej Hellmann, Danuta Radowska, Gary Horwith, Andrew S. Janoff & Robert A. Branch. (2000) A Pharmacokinetic Study of Amphotericin B Lipid Complex Injection (Abelcet) in Patients with Definite or Probable Systemic Fungal Infections. Antimicrobial Agents and Chemotherapy 44:10, pages 2900-2902.
Crossref
Krystyna Konopka, Luke S.S. Guo & Nejat Düzgüneş. (1999) Anti-HIV activity of amphotericin B-cholesteryl sulfate colloidal dispersion in vitro. Antiviral Research 42:3, pages 197-209.
Crossref
Ihor Bekersky, Robert M Fielding, Donald Buell & Ira Lawrence. (1999) Lipid-based amphotericin B formulations: from animals to man. Pharmaceutical Science & Technology Today 2:6, pages 230-236.
Crossref
G. W. Boswell, D. Buell & I. Bekersky. (2013) AmBisome (Liposomal Amphotericin B): A Comparative Review. The Journal of Clinical Pharmacology 38:7, pages 583-592.
Crossref
SPERRY, CUA, WETZEL & ADLER-MOORE. (1998) Antimicrobial activity of AmBisome and non-liposomal amphotericin B following uptake of Candida glabrata by murine epidermal Langerhans cells. Medical Mycology 36:3, pages 135-141.
Crossref
F Gaboriau, M Chéron, C Petit & J Bolard. (1997) Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index. Antimicrobial Agents and Chemotherapy 41:11, pages 2345-2351.
Crossref
François Gaboriau, Monique Chéron, Liliane Leroy & Jacques Bolard. (1997) Physico-chemical properties of the heat-induced ‘superaggregates’ of amphotericin B. Biophysical Chemistry 66:1, pages 1-12.
Crossref
Anya M. Hillery. (1997) Supramolecular lipidic drug delivery systems: From laboratory to clinic A review of the recently introduced commercial liposomal and lipid-based formulations of amphotericin B. Advanced Drug Delivery Reviews 24:2-3, pages 345-363.
Crossref
J BrajtburgJ Bolard. (1996) Carrier effects on biological activity of amphotericin B. Clinical Microbiology Reviews 9:4, pages 512-531.
Crossref
Brian D. Wolf & Scott C. Hartsel. (1995) Osmotic stress sensitizes sterol-free phospholipid bilayers to the action of Amphotericin B. Biochimica et Biophysica Acta (BBA) - Biomembranes 1238:2, pages 156-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.